Takumi Katano

Takumi Katano

Auto-generated profile, based on publicly available information

Takumi Katano

Division of Transplantation and Regenerative Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2019 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
TKTakumi Katano
Takumi Katano
YSYukihiro Sanada
Yukihiro Sanada
YHYuta Hirata
Yuta Hirata
NYNaoya Yamada
Naoya Yamada
NONoriki Okada
Noriki Okada
NSNaohiro Sata
Naohiro Sata

1 January 2023 in Cell Transplantation
Verified
Journal Article
Open access
RSRyusuke Saito
Ryusuke Saito
AIAkiko Inagaki
Akiko Inagaki
YNYasuhiro Nakamura
Yasuhiro Nakamura
TITakehiro Imura
Takehiro Imura
NKNorifumi Kanai
Norifumi Kanai
MGMasafumi Goto
Masafumi Goto
Subcutaneous islet transplantation is a promising treatment for severe diabetes; however, poor engraftment hinders its prevalence. We previously revealed that a gelatin hydrogel nonwoven fabric (GHNF) markedly improved subcutaneous islet engraftment in comparison with intraportal islet transplantation. We herein investigated whether the duration of pretreatment using GHNF affected the outcome of subcutaneous islet transplantation. A silicone spacer with GHNF was implanted into the subcutaneous space of healthy mice at 2, 4, 6, or 8 weeks before transplantation, and then diabetes was induced 7 days before transplantation. Syngeneic islets were transplanted into the pretreated space. Blood glucose, intraperitoneal glucose tolerance, immunohistochemistry, inflammatory mediators, and gene expression were evaluated. The 6-week group showed significantly better blood glucose changes than the other groups ( P < 0.05). The cure rate of the 6-week group (60.0%) was the highest among the groups (2-week = 0%, 4-week = 50.0%, 8-week = 15.4%). The number of von Willebrand factor (vWF)–positive vessels in the 6-week group was significantly higher than in the other groups at pre-islet and post-islet transplantation ( P < 0.01 [vs 2-and 4-week groups] and P < 0.05 [vs all other groups], respectively). Notably, this beneficial effect was also observed when GHNF was implanted into diabetic mice injected with streptozotocin 7 days before GHNF implantation. The positive rates for laminin, collagen III, and collagen IV increased as the duration of pretreatment became longer and were significantly higher in the 8-week group ( P < 0.01). Inflammatory mediators, including interleukin (IL)-1b, granulocyte colony-stimulating factor (G-CSF), and interferon (IFN)-γ, were gradually downregulated according to the duration of GHNF pretreatment and re-elevated in the 8-week group. Taken together, the duration of GHNF pretreatment apparently had an impact on the outcomes of subcutaneous islet transplantation, and 6 weeks appeared to be the ideal duration. Islet graft revascularization, extracellular matrix compensation of the islet capsule, and the inflammatory status at the subcutaneous space would be crucial factors for successful subcutaneous islet transplantation.

9 January 2019 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
YSYukihiro Sanada
Yukihiro Sanada
INItsuki Naya
Itsuki Naya
TKTakumi Katano
Takumi Katano
YHYuta Hirata
Yuta Hirata
NYNaoya Yamada
Naoya Yamada
KMKoichi Mizuta
Koichi Mizuta

1 January 2024 in Cell Transplantation
Verified
Journal Article
Open access
RSRyusuke Saito
Ryusuke Saito
AIAkiko Inagaki
Akiko Inagaki
YNYasuhiro Nakamura
Yasuhiro Nakamura
TITakehiro Imura
Takehiro Imura
NKNorifumi Kanai
Norifumi Kanai
MGMasafumi Goto
Masafumi Goto
Subcutaneous islet transplantation is a promising treatment for severe diabetes; however, poor engraftment hinders its prevalence. We previously revealed that a gelatin hydrogel nonwoven fabric (GHNF) markedly improved subcutaneous islet engraftment. We herein investigated whether the addition of adipose tissue–derived stem cells (ADSCs) to GHNF affected the outcome. A silicone spacer sandwiched between two GHNFs with (AG group) or without (GHNF group) ADSCs, or a silicone spacer alone (Silicone group) was implanted into the subcutaneous space of healthy mice at 6 weeks before transplantation, then diabetes was induced 7 days before transplantation. Syngeneic islets were transplanted into the pretreated space. Intraportal transplantation (IPO group) was also performed to compare the transplant efficiency. Blood glucose, intraperitoneal glucose tolerance, immunohistochemistry, and inflammatory mediators were evaluated. The results in the subcutaneous transplantation were compared using the Silicone group as a control. The results of the IPO group were also compared with those of the AG group. The AG group showed significantly better blood glucose changes than the Silicone and the IPO groups. The cure rate of AG group (72.7%) was the highest among the groups (GHNF; 40.0%, IPO; 40.0%, Silicone; 0%). The number of vWF-positive vessels in the subcutaneous space of the AG group was significantly higher than that in other groups before transplantation ( P < 0.01). Lectin angiography also showed that the same results ( P < 0.05). According to the results of the ADSCs tracing, ADSCs did not exist at the transplant site (6 weeks after implantation). The positive rates for laminin and collagen III constructed around the transplanted islets did not differ among groups. Inflammatory mediators were higher in the Silicone group, followed by the AG and GHNF groups. Pretreatment using bioabsorbable scaffolds combined with ADSCs enhanced neovascularization in subcutaneous space, and subcutaneous islet transplantation using GHNF with ADSCs was superior to intraportal islet transplantation.

26 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
RSRyusuke Saito
Ryusuke Saito
AIAkiko Inagaki
Akiko Inagaki
YNYasuhiro Nakamura
Yasuhiro Nakamura
TITakehiro Imura
Takehiro Imura
NKNorifumi Kanai
Norifumi Kanai
MGMasafumi Goto
Masafumi Goto
Although subcutaneous islet transplantation has many advantages, the subcutaneous space is poor in vessels and transplant efficiency is still low in animal models, except in mice. Subcutaneous islet transplantation using a two-step approach has been proposed, in which a favorable cavity is first prepared using various materials, followed by islet transplantation into the preformed cavity. We previously reported the efficacy of pretreatment using gelatin hydrogel nonwoven fabric (GHNF), and the length of the pretreatment period influenced the results in a mouse model. We investigated whether the preimplantation of GHNF could improve the subcutaneous islet transplantation outcomes in a rat model. GHNF sheets sandwiching a silicone spacer (GHNF group) and silicone spacers without GHNF sheets (control group) were implanted into the subcutaneous space of recipients three weeks before islet transplantation, and diabetes was induced seven days before islet transplantation. Syngeneic islets were transplanted into the space where the silicone spacer was removed. Blood glucose levels, glucose tolerance, immunohistochemistry, and neovascularization were evaluated. The GHNF group showed significantly better blood glucose changes than the control group (p < 0.01). The cure rate was significantly higher in the GHNF group (p < 0.05). The number of vWF-positive vessels was significantly higher in the GHNF group (p < 0.01), and lectin angiography showed the same tendency (p < 0.05). The expression of laminin and collagen III around the transplanted islets was also higher in the GHNF group (p < 0.01). GHNF pretreatment was effective in a rat model, and the main mechanisms might be neovascularization and compensation of the extracellular matrices.

25 April 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
NONoriki Okada
Noriki Okada
YSYukihiro Sanada
Yukihiro Sanada
TUT. Urahashi
T. Urahashi
YIY. Ihara
Y. Ihara
NYN. Yamada
N. Yamada
KMK. Mizuta
K. Mizuta